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Summary
 
A subset of human CD4
 
2
 
CD8
 
2
 
 T cells that expresses an invariant V
 
a
 
24-J
 
a
 
Q T cell receptor
(TCR)-
 
a
 
 chain, paired predominantly with V
 
b
 
11, has been identified. A series of these V
 
a
 
24
V
 
b
 
11 clones were shown to have TCR-
 
b
 
 CDR3 diversity and express the natural killer (NK)
locus–encoded C-type lectins NKR-P1A, CD94, and CD69. However, in contrast to NK
cells, they did not express killer inhibitory receptors, CD16, CD56, or CD57. All invariant
V
 
a
 
24
 
1
 
 clones recognized the MHC class I–like CD16 molecule and discriminated between
CD1d and other closely related human CD1 proteins, indicating that recognition was TCR-
mediated. Recognition was not dependent upon an endosomal targeting motif in the cytoplas-
mic tail of CD1d. Upon activation by anti-CD3 or CD1d, the clones produced both Th1 and
Th2 cytokines. These results demonstrate that human invariant V
 
a
 
24
 
1
 
 CD4
 
2
 
CD8
 
2
 
 T cells,
and presumably the homologous murine NK1
 
1
 
 T cell population, are CD1d reactive and
functionally distinct from NK cells. The conservation of this cell population and of the CD1d
ligand across species indicates an important immunological function.
 
T
 
he CD1 locus encodes a family of conserved nonpoly-
morphic proteins structurally related to MHC class I
and II proteins (1–5). Human and murine CD1-restricted
T cell lines and clones that recognize lipid antigens (6–8) or
hydrophobic peptide antigens (9) have been identified, in-
dicating that CD1 proteins can function as specialized anti-
gen-presenting molecules. A distinct function for murine
CD1d appears to be as a ligand or antigen-presenting mol-
ecule recognized by a population of T cells that express the
NKR-P1C (NK1) cell surface C-type lectin (10–14). NK1
is otherwise restricted to NK cells and these NK1
 
1
 
 T cells
have also been referred to as NK T cells or natural T cells
(15, 16). Phenotypically, these cells are either CD4
 
1
 
CD8
 
2
 
or CD4
 
2
 
CD8
 
2
 
 (double negative, DN
 
1
 
), and forced ex-
pression of CD8 in transgenic mice results in the deletion
of this population (12, 17). Most strikingly, the majority of
these cells use an invariant TCR-
 
a
 
 chain (V
 
a
 
14-J
 
a
 
281)
that pairs preferentially with V
 
b
 
8, 7 or 2 (17–20). NK1
 
1
 
 T
cells appear to play a role in regulating immune responses,
based upon their ability to rapidly produce large amounts
of IL-4 after stimulation with anti-CD3 in vivo (21–24).
However, these cells also produce large amounts of IFN-
 
g
 
,
and production of this cytokine can be specifically induced
by stimulation through NK1 (25). The immunological
functions of these cells and the physiologically relevant
CD1d-presenting cells mediating their activation remain to
be determined.
Analyses of the CD1 genes in humans and other species
indicate that the proteins fall into two groups, CD1a-, b-,
and c-like (group 1), and CD1d-like (group 2) (3, 26). The
murine CD1 locus appears unique in that it has deleted the
group 1 genes, and contains only a duplicated group 2 gene
(27, 28). This observation suggests that there may be im-
portant functional differences between the CD1 proteins in
mice and other species. Nonetheless, a human invariant
TCR-
 
a
 
 chain closely related to the murine invariant V
 
a
 
14-
J
 
a
 
281 TCR has been identified as a predominant TCR
used by TCR-
 
a
 
/
 
b
 
 DN T cells from multiple normal do-
nors (29). This human invariant TCR-
 
a
 
 is generated by a
rearrangement between V
 
a
 
24 (TCRAV24) and J
 
a
 
Q with
no N-region diversity. Subsequent studies have shown that
the human invariant V
 
a
 
24-J
 
a
 
Q TCR-
 
a
 
 chain associates
preferentially with V
 
b
 
11 (TCRBV11) (30–32), which is
homologous to murine V
 
b
 
8. This invariant TCR may also
be expressed by a small proportion of CD4
 
1
 
 T cells, but
not CD8
 
1
 
 T cells (31). These observations suggest that hu-
man invariant V
 
a
 
24
 
1
 
 T cells are homologous to murine
NK1
 
1
 
 T cells.
 
1
 
Abbreviations used in this paper:
 
 CHO, Chinese hamster ovary; DN, dou-
ble negative; KIR, killer cell inhibitory receptor; RT, reverse tran-
scriptase.
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CD1d Recognition by Human T Cells
 
To better understand the function of these cells and their
requirements for specific activation, a series of human in-
variant V
 
a
 
24
 
1
 
V
 
b
 
11
 
1
 
 DN T cell clones were established
and characterized. TCR-
 
b
 
 sequence analysis demonstrated
that these cells were derived from a polyclonal population
with no evidence of a shared 
 
b
 
 chain CDR3 motif. Pheno-
typically, the clones expressed high levels of NKR-P1A,
the only known human homologue of rodent NK1 (33).
They also expressed CD94 and CD69, two other C-type
lectins closely linked to NKR-P1A in a chromosomal re-
gion referred to as the NK locus. However, these cells did
not express the NK cell-associated p58 or p70 HLA class I
killer cell inhibitory receptors (KIRs; 34, 35) or other
markers of NK cells including CD16, CD56, or CD57.
Upon stimulation, the clones secreted cytokines associated
with both Th1 and Th2 cells, including IFN-
 
g
 
 and IL-4,
respectively. Of the four characterized human CD1 pro-
teins, each clone specifically recognized only CD1d ex-
pressed on human or hamster cell transfectants. CD1d rec-
ognition was not dependent upon the specific TCR-
 
b
 
chain CDR3 sequence. Moreover, deletion of an endoso-
mal targeting sequence motif in the cytoplasmic tail of
CD1d (4, 5, 36) did not effect recognition, suggesting that
recognition by these cells was not dependent upon efficient
targeting of CD1d to a specialized endosomal compartment
involved in antigen processing. These results demonstrate
that human invariant V
 
a
 
24
 
1
 
V
 
b
 
11
 
1
 
 DN T cells are a spe-
cialized population of CD1d-specific T cells. The results
also indicate that the similarities between this T cell popu-
lation, and presumably the homologous murine NK1
 
1
 
 T cell
population, to NK cells may be limited to the expression of
certain closely linked NK locus–encoded C-type lectins.
 
Materials and Methods
 
Cell Lines and Clones.
 
T cell lines and clones were derived and
phenotypic analyses performed essentially as described (32). In
brief, DN V
 
a
 
24
 
1
 
V
 
b
 
11
 
1
 
 human peripheral blood T cell lines and
clones were established by sequential negative (CD4CD8) and
positive (V
 
a
 
24V
 
b
 
11) magnetic bead and FACS
 
Ò
 
 sorting, respec-
tively, of human peripheral blood T cells followed by stimulation
with PHA-P (reconstituted according to the supplier’s instruc-
tions and used at a final dilution of 1:2,000; Difco, Detroit, MI)
and IL-2 (1.5 nM; Ajinomoto, Yokohama, Japan) in the presence
of irradiated (5,000 rads) peripheral blood mononuclear cell feed-
ers. Clones were established by limiting dilution. Clones and lines
were maintained by restimulation every 3–6 wk as above with
phenotype monitored by FACS
 
Ò
 
. A human IL-2–dependent NK
cell line, NKL, (37) was provided by Drs. M. Robertson (Indiana
University Medical Center, Indianapolis, IN) and J. Ritz (Dana
Farber Cancer Institute, Boston, MA).
 
Antibodies and Phenotypic Analyses of T Cells.
 
The following anti-
bodies were obtained from the fifth Leukocyte Workshop unless
otherwise indicated: anti-V
 
a
 
24 (C15B2) and anti-V
 
b
 
11 (C21D2)
(provided by Dr. A. Lanzavecchia [Basel Institute for Immunol-
ogy, Basel, Switzerland]); anti–TCR-
 
a
 
/
 
b
 
 (BMA031; provided by
Dr. R.G. Kurrle, Boehringwerke, Marburg, Germany); anti-CD3
(SPV-T3b and OKT3; provided by Dr. H. Spits [Netherlands Can-
cer Center, Amsterdam, Netherlands] and American Type Culture
Collection [Rockville, MD], respectively); anti-CD4 (OKT4;
American Type Culture Collection); anti-CD8
 
a
 
 (OKT8; Ameri-
can Type Culture Collection); anti-CD8
 
b
 
 (2ST8.5H7; from Dr.
E. Reinherz [Dana Farber Cancer Institute]); anti-CD16 (ABA2B1);
anti-CD28 (9.3); anti-CD56 (MEM188, MOC-1, 0218); anti-
CD57 (TB01, TB02); anti-CD69 (PharMingen, San Diego, CA);
anti-CD94 (HP-3D9; PharMingen); anti-NKR-P1A (DX1 and
DX12, provided by Dr. L. Lanier (DNAX, Palo Alto, CA); HP-
3G10 and 191B8); anti-p58 KIR (NK workshop mAbs GL183,
EB6, CH-L, and HP-3E4); and anti-p70 KIR (DX9; provided by
Dr. L. Lanier). Isotype control mAbs were P3 (IgG
 
1
 
), 4A7.6
(IgG
 
2a
 
, provided by Dr. D. Olive [Institut National de la Sante et
de la Recherche Medicale, Marseille, France]), and MPC11
(IgG
 
2b
 
).
CD1d-specific mAbs were raised from mice immunized with
CD1d–IgG fusion proteins. Further characterization of these
CD1d proteins and antibodies will be reported (Balk, S., and S.
Porcelli, manuscript in preparation). CD1d mAbs were purified
from low IgG serum (GIBCO BRL, Gaithersburg, MD) contain-
ing tissue culture medium by protein G (Pharmacia, Piscataway,
NJ) chromatography. FACS
 
Ò
 
 analysis was by indirect immuno-
fluorescence as described (32). Positive controls included an NK
cell line as above and other cell lines and clones derived from pe-
ripheral blood. TCR transcripts were amplified by reverse tran-
scriptase (RT)-PCR using variable and constant region-specific
primers as described previously (29, 38). Sequences were deter-
mined directly from the PCR products on an automated DNA
sequencer (ABI 373A).
 
CD1 Transfectants.
 
Chinese hamster ovary (CHO) and C1R
cells were transfected with a CD1d cDNA (3) in the pSR
 
a
 
-neo
expression vector (39), followed by G418 selection and FACS
 
Ò
 
to generate lines stably expressing CD1d. C1R cells stably trans-
fected with CD1a, b, and c in the pSR
 
a
 
-neo vector were de-
scribed previously (38). The CD1d-CD1a chimeric protein was
generated using an Xba1 restriction site located at the 3
 
9
 
 end of
the 
 
a
 
3 domain in CD1a and CD1d. The C1R line established
with this chimera construct in the pSR
 
a
 
-neo vector was uni-
formly CD1d positive after G418 selection and was used in these
experiments without further enrichment for CD1d
 
1
 
 cells.
 
Functional Analysis of T Cells.
 
T cell activation for cytokine
analysis was done using 10
 
5
 
 T cells/well in 96-well flat-bottomed
plates coated with anti-CD3 at 10 
 
m
 
g/ml for 48 h. Stimulation
with CD1 was done using equal numbers of T cells and stimulator
cells (10
 
5
 
/well) for 48 h, unless otherwise indicated. For CHO
cells, a 30-s glutaraldehyde fixation (0.05% in PBS) was used to
bypass the need for costimulatory molecules (40). For stimulation
by CHO and C1R transfectants, PMA was included at 1 ng/ml,
except where stated otherwise. PHA control stimulations were
carried out using a 2,000-fold dilution as described above. For
antibody blocking experiments, CD1d transfectants were mixed
with mAb dilutions immediately before addition of T cells.
Released cytokine levels were determined by ELISA with
matched antibody pairs in relation to cytokine standards. The an-
tibodies for IFN-
 
g
 
 were from Endogen, Inc. (Boston, MA) and
the others were from PharMingen. T cell proliferation was deter-
mined by incorporation of [
 
3
 
H]thymidine (0.5 mCi/well) using
glutaraldehyde fixed (0.05%) or irradiated (5,000 rads) stimulator
cells where indicated. Results shown are means of triplicate sam-
ples with error bars representing standard deviations.
 
Results
 
Isolation and TCR Analysis of Invariant V
 
a
 
24-J
 
a
 
Q DN T
Cells.
 
Circulating DN T cells were isolated from the pe- 
111
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ripheral blood of two healthy donors (DN1 and DN2) by
anti-CD4 and -CD8 depletion (29, 32). DN Va241 T cells
were then positively selected from these populations using
the C15B12 mAb, specific for Va24 (41), and clones were
established by limiting dilution. Va241 T cell lines from
these populations were also established by bulk stimulation
with PHA, and the majority of the cells in these lines (75–
95%) were found to be Vb111 using the C21D2 mAb
(31). DN and single positive T cells from a third healthy
donor (DN3 and SP3, respectively) were isolated by posi-
tive selection with the Va24 and Vb11 mAbs and cloned
by limiting dilution. As reported previously, the majority of
these latter clones were CD41, but only the DN clones
from this donor expressed JaQ (32).
The TCR structure of a series of eight DN Va241
Vb111 clones from donor 2 and single clones from donors
1 and 3 was analyzed. Sequence analysis demonstrated that
the DN clones from donors 1 and 3 and all but one of the
clones from donor 2 expressed the invariant Va24 TCR-a
chain (Table 1). Significantly, in one invariant Va241
clone (DN2.C7), the Va24-encoded serine was apparently
removed during recombination and the serine was regener-
ated through an N-region addition and recombination 2 bp
further 59 in JaQ (Fig. 1). These results confirmed the high
frequency of the invariant Va24 TCR among DN Va241
T cells, and suggested that this TCR is strongly selected
based upon its protein structure, rather than being gener-
ated exclusively by a developmentally programmed precise
joining of Va24 and JaQ gene segments.
In contrast to the invariant TCR-a structure of the DN
Va241Vb111 clones, multiple distinct TCR-b sequences
were identified (Table 1). The TCR-b sequences from a
series of CD41, Va241Vb111 clones that did not use the
invariant Va24 were also determined for comparison. The
identification of multiple Vb sequences in the clones from
donor 2 demonstrated that the DN invariant Va241 popu-
lation may be derived from a large number of independent
clones in single donors. The TCR-b chains were also
noteworthy for their markedly diverse CDR3 structures
and Jb usage. There was no suggestion of a common CDR3
sequence motif, and even CDR3 length was quite variable.
This TCR-b diversity raised the possibility that these
clones might recognize diverse antigens in spite of their in-
variant TCR-a chain. Alternatively, the lack of conserved
TCR-b chain structure may indicate that the TCR-b
CDR3 did not contribute significantly to recognition by
the TCRs of these cells.
Expression of Cell Surface Proteins Associated with NK
Cells. The relationship between invariant Va241 DN T
cells and NK cells was explored using a panel of mAbs rec-
Table 1. CDR3 Sequences of Va241Vb111 Clones
T cell Va24 JaQ*
TCR-b
Vb11 CDR3 Jb
DN1.10B3 11 CAS REGAMGTGELF FGEG Jb2.2
DN2.B9 11 CAS SATRALTGSDTQY FGPG Jb2.3
DN2.C6 11 CAS SFLDRDYSYNEQF FGPG Jb2.1
DN2.C7 11 CAS SENRQGAGYEQY FGPG Jb2.7
DN2.C9 11 CAS 2 Vb11 sequences‡
DN2.D5 11 CAS SERTTNTGELF FGEG Jb2.2
DN2.D6 11 CAS SVRPGGNEQF FGPG Jb2.1
DN2.D7 11 CAS SDGEQANTEAF FGQG Jb1.1
DN3.2 11 CAS SATIRDRASGYT FGSG Jb1.2
SP3.1 (CD4) 12 CAS SDTRVGGELF FGEG Jb2.2
SP3.4 (CD4) 12 CAS SLGESNQPQH FGDG Jb1.5
SP3.7 (CD4) 12 CAS SVPGPAYEQY FGPG Jb2.7
SP3.11 (CD4) 12 CAS SDTRVGGELF FGEG Jb2.2
SP3.15 (CD4) 12 CAS GTQGNTEAF FGQG Jb1.1
SP3.19 (CD4) 12 CAS EYGGPSYGYT FGSG Jb1.2
*Sequencing confirmed that all JaQ1 TCRs expressed the invariant Va24 TCR-a chain.
‡Sequencing indicated that two Vb11 transcripts were expressed, presumably reflecting two clones.
Figure 1. Invariant Va241 TCR-a nucleotide and derived amino acid
sequences. DN invariant Va241 T cell clone cDNA was sequenced. One
clone (DN2.C7) had a distinct nucleotide sequence, which resulted in an
identical amino acid sequence as shown.112 CD1d Recognition by Human T Cells
ognizing proteins expressed predominantly by NK cells.
Humans appear to have only a single NK1-like gene, the
homologue of murine NKR-P1A, that is expressed by NK
cells and, at low levels, by a subpopulation of peripheral
blood T cells (33). Nonetheless, NKR-P1A was expressed
at high levels by each of the invariant Va241 clones (Table
2 and Fig. 2), but not by any of the CD41 Va241Vb111
clones that did not express the invariant Va24-JaQ rear-
rangement (data not shown).
CD69, CD94, and the NKG2 family are additional
C-type lectins linked to NKR-P1A in the human NK lo-
cus. CD69 is an early and transient T cell activation marker
(42), but expression of CD69 by each of the invariant
Va241 clones persisted at high levels for long periods (.3
wk) after in vitro stimulations (Table 2 and Fig. 2). CD94,
a possible NK cell receptor for class I proteins (43–46), was
also expressed at high levels by all of the invariant Va241
clones. In contrast, prolonged high level expression of these
NK locus–encoded proteins was not observed on any of a
series of similarly derived CD41 clones or on more than a
very small fraction of PHA-stimulated PBLs (data not shown).
Cell surface expression of the NKG2 family (47), members
of which may associate with CD94 (48), could not be as-
sessed as there are no NKG2-specific, surface-reactive NKG2
antibodies readily available (Bach, F., and J. Houchins, per-
sonal communications).
In contrast to the NK locus–encoded C-type lectins,
other functionally important receptors expressed by NK
cells, but encoded at other genetic loci, were not expressed
at significant levels by the invariant Va241 clones. These
included the p58 and p70 HLA class I–specific KIRs, CD16,
CD56, and CD57 (Table 2 and Fig. 2). Finally, each clone
expressed low and variable levels of CD28 and CD8a, but
not CD8b. CD8a was similarly detected at low levels on
some cells from the CD41 Va241 invariant Va242 clones
(Table 2 and data not shown), consistent with its appear-
ance as a late activation antigen. Taken together, these re-
sults further supported the conclusion that human invariant
Va241 T cells and murine invariant Va14-Ja281 NK11
T cells are homologous. However, the relationship of these
cells to classical NK cells appeared limited to their expres-
sion of NK locus genes, but not of genes encoded else-
where that are characteristically expressed by NK cells.
Effector Functions of Invariant Va24 T Cells. Cytokine pro-
duction by the series of invariant Va24Vb11 clones in re-
sponse to stimulation by plate-bound anti-CD3 was assessed.
For comparison, a series of CD41 V a 241-JaQ2 V b 111
clones was also analyzed and IL-4/IFN-g ratios compared
Figure 2. Expression of NK-associated proteins by invariant Va241 T
cells. FACSÒ profiles of a representative DN invariant Va241 T cell clone
(DN2.C9) 4 wk after PHA stimulation. T cells were stained with mAbs
against the antigens shown or isotype-matched control mAb at 10 mg/ml
and with anti-IgG FITC conjugate for 30 min each before FACSÒ analy-
sis with propidium iodide gating on viable cells. (Top, left to right) P3 iso-
type control (open histogram) and Va24 (solid histogram), NKR-P1A,
CD69, CD94. (Bottom, left to right) p58 KIR (GL183 shown), CD16,
CD56, CD57.
Table 2. Expression of NK-associated Proteins by Invariant Va241 T Cells
NK locus molecules NK markers
T Cell CD4 CD8a NKR-P1A CD69 CD94 CD16 CD56 CD57 KIR
DN2.B9 2 6 11 11 11 2 2 2 2
DN2.C6 26 1 1ND 1 ND ND ND 2
DN2.C7 2 6 11 11 11 ND ND ND 2
DN2.C9 2 1 11 11 1 2 6 6 2
DN2.C11 26 1 1ND ND 226 2
DN2.D5 2 6 11 11 1 2 6 2 2
DN2.D6 2 6 11 11 1 2 6 2 2
DN2.D7 2 6 11 11 1 2 2 2 2
SP3.5B2 111 6 2 ND ND 222 2
Summary of DN invariant TCR1 clones and controls FACSÒ data. T cells 2–4 wk after PHA stimulation were stained with mAbs against the anti-
gens shown or isotype-matched controls at 10 mg/ml and anti-IgG FITC conjugate before FACSÒ analysis. 2, ,5% gated positive, MFI ,10; 6,
,50% gated or MFI ,100; 1, .50% gated, MFI ,100; 11, .50% gated, MFI .100; 111, .90% gated, MFI .1,000. a/b-TCR/CD3,
Va24, and Vb11 mAb staining was in the 11 to 111 range. All cells shown were CD8b2. KIR expression was by staining with mAb against four
p58 and the NKB1 p70 molecules (see Materials and Methods).113 Exley et al.
(Table 3). With the exception of DN2.D7, the invariant
Va241 clones all produced substantial levels of IFN-g and
IL-4, associated with Th1 and Th2 T cells, respectively.
Compared to the CD41 clones, there was a trend towards
higher levels of IL-4 production by the invariant Va241
clones, whether assessed based upon absolute IL-4 produc-
tion or IL-4/IFN-g ratios. This contrasts, to some extent,
with an apparent bias in humans towards the generation of
T cells that produce much higher levels of IFN-g relative
to IL-4 (Th1 type cells) in the absence of polarizing stimuli
(49, 50). However, there was overlap between the invari-
ant Va241 DN clones and the CD41 clones with respect
to IL-4 and IFN-g production, and IL-4/IFN-g ratio, in-
dicating that the invariant Va241 DN T cells had a pheno-
type that did not fall clearly into the Th1 or Th2 categories.
The DN clones also produced IL-13, and some produced
IL-10 at levels that were not clearly distinct from the
CD41 cells.
Recognition of CD1d-transfected CHO Cells by DN Invariant
Va241 Clones. CD1d recognition was assessed initially us-
ing CD1d-transfected CHO cells. Each of the five invari-
ant Va241 clones assayed responded specifically to the
CD1d-transfected CHO cells based upon T cell prolifera-
tion (not shown) and cytokine release (Fig. 3). Recogni-
tion of CD1d required PMA and mild aldehyde fixation of
the target cells, which have been shown in other systems to
substitute for certain physiological costimulatory signals
(40). Fig. 3 a shows that the CD1d transfectants stimulated
IL-4 production from each of the clones except DN2.C9,
with the highest levels produced by DN2.B9 and DN2.D6.
The CD1d transfectants also strongly stimulated IFN-g
production from three of these clones (DN2.B9, DN2.C9,
and DN2.D6) and modest, but specific, IFN-g release by
the other two clones (Fig. 3 b). In contrast, the invariant
Figure 3. Invariant Va241 T
cells responded to CD1d CHO
transfectants specifically. DN in-
variant Va241 T cell clones
(DN2.B9,  C6,  C7,  C9, and D6)
and control CD41 V a 241 in-
variant TCR-negative T cell
clones (SP3.4G9 and 5B2), all at
2  3 105/well were stimulated
with 0.05% glutaraldehyde-
fixed CD1d1 CHO transfectants
or control CHO cells (2 3 105/
well). PMA (1 ng/ml) and IL-2
(1 nM) were included, and se-
creted IL-4 and IFN-g measured
at 48 h by ELISA in triplicate
(standard deviations shown).
Similar results were obtained
without IL-2. (a) IL-4; (b) IFN-g.
Table 3. Cytokine Responses of Invariant TCR1 T Cells to Mitogenic Stimulus
T cell IFN-g IL-4 IL-10 IL-13 GM-CSF IL-4/IFN-g
DN2.B9 7,743 2,498 ,100 7,853 6,410 0.323
DN2.C6 20,480 8,723 12,690 3,379 15,510 0.435
DN2.C7 31,300 10,780 ,100 34,240 32,690 0.345
DN2.C9 13,390 1,658 ,100 4,557 6,670 0.123
DN2.D5 9,536 5,304 5,660 11,960 12,940 0.556
DN2.D6 31,180 15,720 15,300 63,895 68,500 0.500
DN2.D7 5,919 414 6,220 1,520 9,880 0.070
SP3.3B2 8,491 1,681 34,910 26,770 23,190 0.196
SP3.3D10 35,390 1,942 88,980 19,690 35,330 0.055
SP3.4C6 39,710 1,903 218,200 24,590 28,050 0.048
SP3.4G9 21,060 767 ,100 24,120 39,420 0.036
SP3.5B2 2,656 4,723 ,100 17,270 6,700 1.667
T cells (105/well) were stimulated with plate-bound mAb (10 mg/ml) against CD3 or NKR-P1A, supernatants collected at 48 h, and ELISA was
with cytokine mAb pairs and standards (PharMingen), results shown as pg/ml. Antibody-free and isotype control mAb wells had ,610 pg/ml of all
cytokines tested. Detection limits were ,100 pg/ml for cytokine ELISA. Similar results, with slightly higher responses and backgrounds, were ob-
tained in the presence of 1 nM IL-2. T cell proliferation was also determined at 96 h (not shown).114 CD1d Recognition by Human T Cells
Va242 clones did not respond specifically to the CD1d
transfectants (Fig. 3, a and b, and data not shown). The fail-
ure of the DN2.C9 clone to produce significant IL-4 in re-
sponse to the CD1d transfectant was consistent with the
relatively low ratio of IL-4/IFN-g produced by this clone
in response to anti-CD3 stimulation (Table 3). Indeed, the
relative levels of IL-4 and IFN-g release in response to
CD1d from each of the clones were comparable to those
observed with anti-CD3 (Table 3).
Antibody inhibition studies were performed to confirm
that CD1d was recognized and to rule out the possibility
that peptide fragments of CD1d were the actual target of
the invariant Va241 clones. Two mAbs that recognized
native CD1d protein (42.1 and 51.1) could almost com-
pletely block activation of the DN2.D6 T cell clone at
concentrations  >0.2  mg/ml (Fig. 4 and data not shown). A
third anti-CD1d mAb (68.2) partially blocked, but only at
higher concentrations. Several isotype-matched control an-
tibodies used for blocking had no significant effect. Directly
comparable results were seen with the second clone ana-
lyzed (DN2.D5; data not shown).
Recognition of CD1d-expressing B Cell Transfectants. Stimu-
lation of invariant Va241 T cells by CD1d1 CHO cells re-
quired both PMA and aldehyde fixation, presumably due
to the absence of necessary costimulatory ligands on the
CHO cells. Although the target cells that mediate activa-
tion of invariant Va241 T cells in vivo are not known,
normal B cells express CD1d (51) and may be a relevant
CD1d-presenting cell. Therefore, the C1R HLA-A and -B
negative B lymphoblastoid cell line (52), which does not
express detectable CD1d (our unpublished data), was used
to confirm the results in CHO cells and to determine
whether the need for nonphysiological costimulation could
be reduced or eliminated. CD1d-transfected C1R cells
specifically stimulated each of the invariant Va241 DN T
cell clones tested based upon IFN-g and IL-4 production
and T cell proliferation (Fig. 5 a and data not shown), con-
firming the results in CHO cells. Stimulation did not re-
quire aldehyde fixation, but phorbol ester was still necessary.
The fine specificity of CD1d recognition was further as-
sessed using C1R cells stably transfected with CD1a, b, or c
versus CD1d. The CD1a, b, and c transfectants were not
significantly more active than the mock transfectant in
stimulating IFN-g (Fig. 5 b) or IL-4 production (not shown)
from any of the clones examined, although they were able to
stimulate CD1a–, b–, or c–reactive T cell clones, respec-
tively (6, 53). In marked contrast, the CD1d C1R transfec-
tants stimulated the production of IFN-g (Fig. 5 b) and IL-4
(not shown) at levels directly comparable to those pro-
duced in response to PHA.
CD1d Recognition by Invariant Va241 T Cells Not Expressing
Vb11. Polyclonal DN T cell lines selected for expression
of Va24 were sorted into Vb111 or Vb112 populations and
examined to determine whether Vb11 was necessary for
CD1d recognition. FACSÒ analyses showed that virtually all
of the cells in both lines were Va241 (Fig. 6 a), and previous
Figure 5. Invariant Va241 T
cells responded to CD1d B cell
transfectants. T cell clones (105/
well) were incubated for 48 h
with either fixed (0.025 or 0.05%
glutaraldehyde, latter shown) or
unfixed C1R human B cells
(105/well) transfected with CD1a,
b, c, d, or plasmid alone. Results
with the two fixations were indis-
tinguishable. PMA (1 ng/ml) was
included and PHA as positive
control is shown for comparison.
Representative IFN-g cytokine
ELISA results of multiple experi-
ments are shown. (a) Production
of IFN-g by DN2.C9 incubated
for 48 h with C1R 6 fixation.
(b) IFN-g cytokine responses of
three representative DN2 T cell
clones incubated for 48 h with
unfixed C1R transfected with
CD1a, b, c, d, mock, or mock
with PHA.
Figure 4. CD1d antibodies
inhibited invariant Va241 T cell
recognition of targets. DN in-
variant Va241 T cell clone
DN2.D5 (105/well) was stimu-
lated with fixed CD1d1 CHO
cell transfectants (105/well) as in
Fig. 3. Control and CD1d-spe-
cific mAb were included at 0.67
mg/ml, and secreted IFN-g mea-
sured by ELISA. Higher concen-
trations of mAb gave similar results
except for 68.2, where inhibition
was more complete.115 Exley et al.
RT-PCR analyses of these lines showed that both expressed
primarily or exclusively the invariant Va24 (32). The line
designated as DN2.Vb112 had no significant Vb111 popula-
tion, whereas the line designated as DN2.Vb111 was virtu-
ally all Vb111 (Fig. 6 a). It is of interest that cells in the
Vb112 line consistently expressed slightly lower TCR lev-
els, based upon staining with the anti-Va24 mAb (Fig. 6 a)
and anti-TCR mAbs (not shown). The relationship of this
observation to the preferential use of Vb11 by invariant
Va241 T cells is not clear, but could reflect greater stability
of the invariant Va24 when paired with Vb11.
CD1 recognition by cells in both lines was compared us-
ing the panel of CD1-transfected C1R cells. Both the
Vb111 and Vb112 lines were activated specifically by the
CD1d-transfected C1R cells (Fig. 6 b). Although the re-
sponse by the Vb112 line was quantitatively less, the re-
sponses by both lines were comparable to the correspond-
ing PHA responses and most likely represented maximal
activation for each line. These results demonstrated that
T cells expressing the invariant Va24 TCR-a paired with
Vbs other than Vb11 can mediate CD1d recognition.
Contribution of the CD1d Endoplasmic Targeting Motif to
Recognition. Human CD1b, c, d, and murine CD1d, but
not human CD1a, have short cytoplasmic tails containing a
sequence motif, Tyr-X-X-Z (where X is any amino acid
and Z is a hydrophobic amino acid), shown to regulate the
intracellular trafficking of many transmembrane proteins
(54). Previous studies demonstrated a critical role for this
motif in the endosomal localization of human CD1b (36).
To determine whether this sequence is necessary for the
cell surface expression and function of CD1d, the trans-
membrane domain and cytoplasmic tail from CD1a was
fused to the CD1d ectodomain. A C1R cell line trans-
fected with this CD1d-CD1a chimera expressed moderate
levels of CD1d at the cell surface (Fig. 7 a). The level of
CD1d expression was lower than in the C1R line express-
ing wild-type CD1d, as this latter line was initially sorted
for CD1d1 cells.
Despite lower levels of CD1d expression, the C1R cells
expressing the CD1d-CD1a chimeric protein were very ef-
fective at activating invariant Va241 clones. The DN2.D5
clone produced both IFN-g (Fig. 7 b) and IL-4 (not shown)
in response to the chimeric protein at levels comparable to
those induced by PHA stimulation. Identical results were
seen with a second clone, DN2.D6 (not shown). There-
fore, deletion of the targeting motif did not impair CD1d
recognition by invariant Va241 DN T cells.
Discussion
This report demonstrated the expression of invariant
Va241 TCRs by a distinct population of CD1d-reactive
DN T cells that appear to be closely related, both pheno-
typically and functionally, to murine NK11 T cells. A se-
Figure 6. Invariant Va241 T
cells that did not express Vb11
responded to CD1d. (a) Repre-
sentative FACSÒ profiles of
two DN invariant TCR1 T cell
lines (DN2.Vb111, left; and
DN2.Vb112, right). T cells
were stained with 10 mg/ml of
mAbs against Va24, Vb11, or
isotype control mAb and with
anti-IgG FITC conjugate for 30
min each before FACSÒ analysis
of viable cells. (b) T cell lines
(105/well) were incubated with
unfixed C1R human B cells
(105/well) transfected with CD1a,
b, c, d, mock, or mock with
PHA as in Fig. 5 and IFN-g pro-
duction results are shown.
Figure 7. Invariant Va241 T
cells responded to chimeric CD1d
with intracellular CD1a. (a) FACSÒ
profiles of C1R CD1d (left) and
CD1d/a chimera (right) transfec-
tants stained with normal mouse
serum (open histogram) or 42.1
CD1d-specific mAb (solid histo-
gram). (b) DN2.D6 T cell clone
(105/well) was incubated with
unfixed C1R human B cell
CD1d/a chimera or mock trans-
fectants (105/well) and IFN-g
cytokine ELISA results obtained.116 CD1d Recognition by Human T Cells
ries of invariant Va241Vb111 DN T cell clones were
shown to recognize CD1d expressed either by a hamster
(CHO) or human B cell (C1R) line. The fine specificity of
this recognition was demonstrated by the failure of these
clones to recognize CD1a, b, or c transfectants. Moreover,
antibody blocking studies indicated that intact CD1d,
rather than peptides derived from this protein, were recog-
nized by these clones. These results provided strong evi-
dence that CD1d recognition by these clones was mediated
directly by their TCRs.
The Vb11 chains from these clones were sequenced to
determine whether this population was monoclonal or
polyclonal and whether there were structural constraints on
the CDR3 region. This analysis revealed a unique Vb11
chain with extensive N-region diversity in each of the
clones isolated from a single donor, demonstrating that
multiple independently derived clones contributed to this
population. Sequence analysis of the Va24-JaQ chains also
revealed a clone with distinct codon usage in the V-J junc-
tion, indicative of N-region addition. These observations
suggest that the TCRs used by these clones are generated
through V-(D)-J recombination mechanisms and subse-
quent positive selection as with conventional T cells.
The Vb11 sequence analysis also revealed the lack of ap-
parent structural constraints on the CDR3 region, since
there was marked variability in CDR3 length, Jb usage,
and sequence. There was no suggestion of a sequence motif
that distinguished the Vb11 CDR3 regions associated with
the invariant Va24 chain from those associated with other
noninvariant Va24 chains. This pattern of CDR3 indepen-
dent recognition by one or several Vb chains could be
consistent with selection or expansion by a superantigen
(possibly CD1d associated). However, conventional super-
antigen recognition is not dependent upon a Va chain
CDR3. It also appeared unlikely that these heterogeneous
Vb11 chains mediated recognition of distinct CD1d-pre-
sented antigens since each clone recognized CD1d ex-
pressed by both hamster and human cells without the de-
liberate addition of an antigen. Therefore, the current data
suggest that Vb11 may be structurally favored as an invari-
ant Va24 partner and/or mediate direct contacts with
CD1d. However, pairing of the invariant Va24 with Vb11
was not an absolute requirement for CD1d recognition
since analysis of an invariant Va241Vb112 DN T cell line
demonstrated that the invariant Va24 can pair with other
Vbs to generate CD1d-reactive TCRs.
Although CD1d recognition by multiple clones was
demonstrated without the deliberate addition of an antigen,
this did not rule out CD1d presentation of one or a small
number of conserved ubiquitous endogenous or serum-
derived antigens. CD1 has been shown to present lipid an-
tigens (6–8, 53) and hydrophobic peptide antigens (9).
Consistent with these observations, the crystal structure of
murine CD1d reveals a potential deep hydrophobic anti-
gen-binding cavity (55). The pathway(s) through which
CD1 may acquire such hydrophobic or other antigens are
not clear, but appear distinct from the MHC class I pathway
(6, 56–58). Significantly, the cytoplasmic tails of human
CD1b, c, and d, and murine CD1d contain a short tyrosine-
based signal that has been implicated in trafficking from the
plasma membrane to endosomal compartments (54), and a
recent immunogold electron microscopy study demon-
strated that a large fraction of CD1b molecules were lo-
cated intracellularly in an endosomal compartment (36).
Based upon these observations, one hypothesis has been
that CD1 proteins are targeted to an acidic endosomal
compartment and are there loaded with antigen.
To address this hypothesis in the case of CD1d, the cyto-
plasmic tail of CD1d was replaced with the cytoplasmic tail
of CD1a, which lacks recognizable targeting motifs. CD1a
proteins appear to traffic to the cell surface through the de-
fault secretory pathway and do not enter an endosomal
compartment (Sugita, M., M. Brenner, and S. Porcelli, un-
published data). The chimeric protein was recognized by
invariant Va241 DN T cell clones despite the loss of the
endosomal targeting signal, indicating that endosomal traf-
ficking mediated by this signal was not necessary for CD1d
recognition by this cell population. Taken together, the
data in this report indicate that T cell recognition of CD1d
mediated by the invariant Va24 TCR may not involve a
specific antigen, although presentation of a conserved cel-
lular antigen acquired through a pathway that is indepen-
dent of the endosomal targeting motif cannot be excluded.
Moreover, it remains possible that CD1d presents specific
foreign antigens in vivo and that the in vitro responses re-
flect relatively low affinity interactions mediated by CD1d
binding to diverse nonspecific antigens.
In addition to specific antigen recognition by the TCR,
the activation of conventional T cells is dependent upon
the recruitment of p56lck to the TCR complex by the CD4
or CD8 accessory proteins. The invariant Va241 DN
clones express p56lck (data not shown) and it is very likely
that there are other accessory proteins that couple it to the
TCR in these cells. The consistent high level expression of
NKR-P1A by human invariant Va241 DN T cell clones,
the expression of NK1 (NKR-P1C) by the homologous
murine cell population, and the presence of a p56lck bind-
ing motif in the cytoplasmic tails of the murine NKR-P1
proteins make these clear candidate accessory proteins (59,
60). However, the presence of invariant Va1 T cells in
mouse strains that do not express NK1 or other NKR-P1
proteins argues against such a critical role for NKR-P1. It
should also be noted that the human NKR-P1A protein
does not contain the putative p56lck binding site (33) and,
in preliminary biochemical studies, we have been unable to
demonstrate an association between human NKR-P1A and
p56lck (Exley, M., unpublished data).
The human invariant Va241 T cell clones also expressed
two other C-type lectins, CD69 and CD94, encoded in a
chromosomal region that has been termed the NK locus.
CD94 may heterodimerize with NKG2 proteins (48), an-
other family of C-type lectins encoded in the NK locus
(47), and this complex may be an MHC class I receptor
(44, 48). CD69 is an early and transient T cell activation
antigen (42), but its expression by invariant Va241 DN T
cell clones was persistent. This suggests that invariant117 Exley et al.
Va241 DN T cells may remain in an activated state longer
than conventional T cells. Alternatively, given the high
level of expression of other NK locus–encoded proteins
observed on invariant Va241 T cells, CD69 expression
may reflect constitutive transcriptional activity of the NK
locus in these cells which is not directly related to T cell ac-
tivation.
Although the expression of NKR-P1 and CD94 at high
levels suggests some relationship to NK cells, the invariant
Va241 DN T cells did not express a number of other mol-
ecules that play roles in NK cell function, such as CD16,
CD56, and CD57. In particular, the invariant Va241 DN
T cells did not express p58 or p70 KIRs, although expres-
sion of family members not recognized by the multiple an-
tibodies used here remains possible. Consistent with the
mAb data, preliminary RT-PCR amplification experi-
ments with consensus KIR primers have similarly failed to
detect KIR expression (data not shown). This is in contrast
to recent data showing that KIRs may be expressed in
other T cell subpopulations (61–64). These observations
indicate that the link between invariant Va241 DN T cells
and NK cells may be transcriptional activation of the NK
locus, with limited functional overlap between these cell
populations.
Cytokine production by invariant Va241 DN T cells
was also analyzed and the results supported conclusions
reached in the mouse that these cells can produce signifi-
cant levels of IL-4 in response to activation (20–23). How-
ever, they also produced other cytokines, particularly IFN-g,
at substantial levels, and their regulatory functions in vivo
are probably complex. Murine NK11 T cells are responsi-
ble for the acute production of IL-4 in response to anti-
CD3 in vivo (23), but this type of stimulus is clearly non-
physiological. It is unlikely that the function of this cell
population is to determine systemic levels of IL-4 or other
cytokines, and more likely that the IL-4 produced in re-
sponse to anti-CD3 stimulation reflects the primed activa-
tion state of these cells in vivo. A reasonable alternative hy-
pothesis is that invariant Va241 T cells function through
cell–cell interactions to provide individual CD1d1 target
cells with IL-4, IFN-g, or other cytokines that in turn di-
rect the further proliferation and/or differentiation of these
target cells.
B cells express CD1d (51) and represent one possible tar-
get cell for invariant Va241 T cells. However, CD1d may
also be widely expressed (51, 65) and invariant Va241 T
cells may, therefore, have functionally important interac-
tions with a number of different cell types. In particular,
the large fraction of T cells in murine bone marrow and
liver that are NK11 (66, 67) presumably interact locally
with CD1d1 cells and may play roles in regulating B cell
maturation, myeloid development, or hepatic immune
function. Finally, recent reports indicate that loss of invari-
ant Va241 T cells in humans or of the homologous NK11
T cell population in mice is associated with disease progres-
sion in several autoimmune diseases (68–70). Although the
precise functions of invariant Va241 T cells and their mu-
rine homologues remain to be clarified, the conservation of
this cell population and of the CD1d ligand across species
suggests an important immunological function.
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